MECOM, HBS1L-MYB, THRB-RARB, JAK2, and TERT polymorphisms defining the genetic predisposition to myeloproliferative neoplasms: A study on 939 patients

This study examined three polymorphisms—MECOM rs2201862, HBS1L-MYB rs9376092, and THRB-RARBrs4858647—and impact on the risk of developing MPN. 

 Am J Hematol

By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.